Company / PP&E per Share
MADRIGAL PHARMACEUTICALS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.07
FY2025
5-year range
$0.04 / $0.11
FY2021-FY2025
Trend
-38.2%
vs FY2024
Sector context
#109 of 191
Health Care
What the data says
At $0.07, MADRIGAL PHARMACEUTICALS, INC.'s pp&e per share ranks #109 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2016 to $0.11 in FY2024.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of +0.1%.
Declined from $0.09 to $0.07 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +24.8%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Sector benchmark
#109 of 191 in Health CareTop 57% of 191This company $0.07 Sector average $22.34
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 38.2% year-over-year.
- Ranks #109 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -38.2% |
| FY2024 | $0.11 | +28.4% |
| FY2023 | $0.09 | +144.6% |
| FY2022 | $0.04 | -36.1% |
| FY2021 | $0.05 | -19.1% |
| FY2020 | $0.07 | -11.8% |
| FY2019 | $0.08 | +401.3% |
| FY2018 | $0.02 | -37.6% |
| FY2017 | $0.02 | +4164.6% |
| FY2016 | $0.00 | -95.2% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026